Peptide research, explained.
Detailed guides to peptide identity, biological pathways, analytical methods and clinical evidence. Search the reading room or follow a research topic.
Browse 13 research topics
All guides & articles
Research PracticeEcnoglutide: What cAMP-Biased GLP-1 Signaling Means
Ecnoglutide is described as a cAMP-biased GLP-1 receptor agonist. That is a statement about signaling in an assay, not a clinical verdict that the molecule works better than all other GLP-1 medicines.
Updated 2026-10-29 ↗
Research PracticeEfpeglenatide: Reading the AMPLITUDE-O Outcome Trial
AMPLITUDE-O evaluated efpeglenatide in people with type 2 diabetes and high cardiovascular or kidney-related risk.
Updated 2026-10-29 ↗
Research PracticeEloralintide: Selective Amylin Design and the 48-Week Trial
Eloralintide research links a molecular design question with a human weight-management question.
Updated 2026-10-29 ↗
Peptide FundamentalsEnfuvirtide: A Peptide That Targets HIV Fusion
Enfuvirtide is a peptide antiretroviral that targets a stage of HIV-1 entry: fusion of viral and cellular membranes.
Updated 2026-10-29 ↗
Peptide FundamentalsEptifibatide vs Tirofiban: Same Platelet Target, Different Molecules
Eptifibatide and tirofiban act at platelet glycoprotein IIb/IIIa, yet their structures are different: eptifibatide is a cyclic peptide and tirofiban is a nonpeptide antagonist.
Updated 2026-10-29 ↗
Peptide FundamentalsExenatide and Exendin-4: A Different GLP-1 Peptide Design
Exenatide is related to exendin-4 and acts at the GLP-1 receptor, but the product’s formulation remains central to its evidence.
Updated 2026-10-29 ↗
Research PracticeGlepaglutide: What the EASE SBS-1 Trial Measured
EASE SBS-1 measured whether glepaglutide reduced parenteral support needs in people with short bowel syndrome and intestinal failure.
Updated 2026-10-29 ↗
Research PracticeGLP-1 Drugs and Gallbladder Events: What the Studies Show
A gallstone, gallbladder inflammation and obstruction of the biliary tract are related outcomes, but they are not interchangeable.
Updated 2026-10-29 ↗
Research PracticeGLP-1 Drugs and Gastroparesis: Delay, Symptoms and Diagnosis
Delayed gastric emptying is a measured physiological effect. Gastroparesis is a clinical diagnosis that requires more context than a delayed measurement alone.
Updated 2026-10-29 ↗
Research PracticeGLP-1 Weight Loss and Muscle Loss: What DXA Can Tell You
A headline about GLP-1 muscle loss may be describing a DXA estimate of lean tissue, the proportion of lost weight classified as lean, or a direct measure of strength.
Updated 2026-10-29 ↗
Peptide FundamentalsGlucagon: Why Rescue Medicine and Metabolic Coagonism Differ
Glucagon rescue medicines and glucagon-containing metabolic coagonists use a related biological pathway to answer different clinical questions.
Updated 2026-10-29 ↗
Peptide FundamentalsIcatibant: Why Bradykinin-Mediated Angioedema Is a Different Target
Icatibant targets the bradykinin B2 receptor. That mechanism is why its hereditary-angioedema evidence should be read separately from familiar allergy narratives centered on histamine.
Updated 2026-10-29 ↗